tirzepatide vs semaglutide appetite suppression Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management GLP-1 Genetics: How Genes Affect

The real question isnt which drug wins in a study? Its which one can you tolerate, afford, and stay on long enough to hit an effective dose? Side Effects: What to Expect Both medications cause similar side effects because they work on overlapping pathways

Retrieved May 13, 2022, from [2] FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes

Semaglutides Role in Diabetes and Obesity Care Semaglutide has a powerful dual role in modern medicine, effectively treating both type 2 diabetes and obesity

Tirzepatide has shown substantial weight loss benefits, leading to its approval under the name Zepbound for obesity and overweight treatment

Ozempic is a GLP-1 receptor agonist that supports blood sugar control by enhancing insulin secretion and reducing appetite, often leading to weight loss